|
WO2021017892A1
|
|
Method and composition for anti-cd73 antibodies and variants
|
|
CN110923366A
|
|
Method for on-line monitoring yield and quality of target protein
|
|
CN110818795A
|
|
anti-TIGIT antibodies and methods of use
|
|
CN110787292A
|
|
Programmed cell death receptor 1 antibody preparation and application thereof
|
|
US2019218295A1
|
|
Anti-pd-1 antibodies
|
|
CN109627337A
|
|
A kind of monoclonal antibody and its preparation method and application of anti-PRLR
|
|
CN111375057A
|
|
Pharmaceutical formulation comprising anti-Her 2 monoclonal antibody
|
|
CN109134651A
|
|
A kind of monoclonal antibody of anti-vegf and its preparation method and application
|
|
CN109134655A
|
|
A kind of monoclonal antibody and its preparation method and application of anti-PDGFR α
|
|
EP3532100A1
|
|
Anti-pd-l1 antibodies and variants
|
|
KR20190051037A
|
|
Anti-PD-1 antibody
|
